Sort   by:  
 Page size 
UnknownEffect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus.
Not available
S-EPMC6394354 | biostudies-literature
UnknownImpact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases.
Not available
S-EPMC6620879 | biostudies-literature
UnknownNew approach to determine the healthy immune variations by combining clustering methods.
Not available
S-EPMC8076194 | biostudies-literature
UnknownDeficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
Not available
S-EPMC1774122 | biostudies-literature
UnknownThe identification of blood-derived response eQTLs reveals complex effects of regulatory variants on inflammatory and infectious disease risk.
Not available
S-EPMC12013874 | biostudies-literature
UnknownCommon variants in the NLRP3 region contribute to Crohn's disease susceptibility.
Not available
S-EPMC2728932 | biostudies-literature
UnknownMonoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
Not available
S-EPMC6391094 | biostudies-literature
UnknownAbnormalities in normal-appearing white matter from which multiple sclerosis lesions arise.
Not available
S-EPMC8453433 | biostudies-literature
UnknownGenetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
Not available
S-EPMC2745755 | biostudies-literature
UnknownNovel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.
Not available
S-EPMC1853118 | biostudies-literature
Sort   by:  
 Page size